[匈牙利心力衰竭患者短期死亡率的决定因素]
Ágnes Anita Tóth1, Fruzsina Mária Sinka2, Éva Belicza1,2
11 Semmelweis Egyetem, Egészségügyi Menedzserképző Központ, Adatvezérelt Egészség Divízió-Egészségbiztonság Nemzeti Laboratórium Budapest Magyarország.
Orvosi hetilap
|October 19, 2025
概括
早期使用指南推药物的心力衰竭患者的死亡率较低. 在匈牙利观察到心力衰竭护理和结果的区域差异,突出了改善治疗坚持的必要性.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 心力衰竭 (HF) 是全球主要的死亡原因,需要优化治疗策略以改善患者预后.
- 行政卫生数据库提供了一个强大的工具,用于对高频率患者的临床结果和治疗模式进行大规模评估.
- 了解短期死亡率及其决定因素对于有效的高频率管理至关重要.
研究的目的:
- 调查匈牙利心力衰竭患者的短期死亡率.
- 分析治疗策略与心力衰竭死亡率之间的关联.
- 确定影响心力衰竭结果的人口,临床和区域因素.
主要方法:
- 对2012-2020年匈牙利国家健康保险基金 (NEAK) 数据的回顾分析.
- 纳入标准:ICD-10 I50 代码用于心力衰竭在心声回声图的两个月内.
- 评估人口特征,并发病,药物使用,住院病史和90天死亡率.
主要成果:
- 分析了超过25万名患者;女性性别与较低的死亡率相关,而晚年 (80-89岁) 显著增加了风险.
- 在诊断前,指南推的药物处方与90天死亡率大幅降低有关.
- 较长的先前住院时间增加了三倍的死亡风险;死亡风险的区域差异显著.
结论:
- 行政数据为心力衰竭死亡率提供了宝贵的见解,但需要谨慎解释.
- 在匈牙利存在异质性心力衰竭管理和结果的显著区域差异.
- 对伴随性疾病的早期基于证据的药物治疗可能比单独的诊断后治疗更有效; 诊断前药物治疗的好处需要进一步研究.
关键词:
伴随性疾病发生率.药物制剂可以化.心脏衰竭是因为心脏衰竭.风险因素 风险因素死亡率 死亡率死亡率是死亡率.药物治疗药物治疗有关风险因素的风险因素.这是一个令人难以置信的无限度.társ疾病的一些疾病.更多相关视频
相关概念视频
01:27Heart Failure I: Introduction
678
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
678
01:30Heart Failure V: Medical Management
215
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
215
01:17Pathophysiology of Heart Failure
2.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.8K
01:30Heart Failure VII: Nursing Interventions
413
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
413
01:22Heart Failure VI: Adjunct Therapies
252
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
252
01:29Heart Failure II: Pathophysiology
707
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
707